|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4196 | (2006.01) |
| A61P 7/00 | (2006.01) | ||
| A61P 3/12 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 2026801 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07840190.8 |
| Date of filing the European patent application | 2007-05-21 | |
| (97) | Date of publication of the European application | 2009-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-06 |
| (46) | Date of publication of the claims translation | 2014-02-25 |
| (86) | Number | PCT/US2007/069319 |
| Date | 2007-05-21 |
| (87) | Number | WO 2008/005624 |
| Date | 2008-01-10 |
| (30) | Number | Date | Country code |
| 747974 P | 2006-05-23 | US | |
| 803049 P | 2006-05-24 | US | |
| 835658 P | 2006-08-04 | US |
| (72) |
NICK, Hanspeter, CH
ROJKJAER, Lisa, US
BODNER, Janet Ellen, US
MARKS, Peter Wayne, US
|
| (73) |
Novartis AG,
Corporate Intellectuel Property, CH-4002 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Deferasiroksas, skirtas paveldimos hemochromatozės gydymui |
| Deferasirox for the treatment of hereditary hemochromatosis |
| Payment date | Validity (years) | Amount | |
| 2017-05-04 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-05-21 |